A Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleukin-11
Clinical trial NCT06759636 · RECRUITING
Trial details
- NCT number
- NCT06759636
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-24
- Primary completion
- 2026-04-21
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.